NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 122 filers reported holding NURIX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $129,780 | +66114.3% | 12,991 | -41.2% | 0.00% | -33.3% |
| Q1 2023 | $196 | -19.3% | 22,106 | -0.3% | 0.00% | -40.0% |
| Q4 2022 | $243 | -99.9% | 22,162 | -0.2% | 0.01% | -16.7% |
| Q3 2022 | $289,000 | +12.0% | 22,197 | +9.1% | 0.01% | -14.3% |
| Q2 2022 | $258,000 | -18.4% | 20,349 | -9.8% | 0.01% | 0.0% |
| Q1 2022 | $316,000 | -56.1% | 22,549 | -9.3% | 0.01% | -41.7% |
| Q4 2021 | $719,000 | – | 24,849 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |